QQ客服 官方微博 反馈留言

	Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody
	Wen, Feng; Tang, Ruilei; Sang, Yaxiong; Li, Meng; Hu, Qiancheng; Du, Zedong; Zhou, Yi; Zhang, Pengfei; He, Xiaofeng; Li, Qiu
刊名	CANCER SCIENCE
	2013
卷号	Vol.104 No.10页码:1330-1338
ISSN号	1349-7006
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1839480
专题	四川大学
作者单位	1.Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Med Oncol,Canc Ctr, Chengdu 610064, Sichuan, Peoples R China 2.First Peoples Hosp Longquanyi Dist, Dept Med Oncol, Chengdu, Sichuan, Peoples R China 3.Hosp, Dept Oncol, Chengdu, Sichuan, Peoples R China 4.Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Wen, Feng,Tang, Ruilei,Sang, Yaxiong,et al. Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody[J]. CANCER SCIENCE,2013,Vol.104 No.10:1330-1338.
APA	Wen, Feng.,Tang, Ruilei.,Sang, Yaxiong.,Li, Meng.,Hu, Qiancheng.,...&Li, Qiu.(2013).Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.CANCER SCIENCE,Vol.104 No.10,1330-1338.
MLA	Wen, Feng,et al."Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody".CANCER SCIENCE Vol.104 No.10(2013):1330-1338.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。